Dalrada disputes $1.16M claim under unfunded credit
Rhea-AI Filing Summary
Dalrada Technology Group, Inc. (DHTI) reports that its wholly owned subsidiary Genefic, Inc. and related affiliates entered into a $20,000,000 Master Performance Standby Letter of Credit and Guaranty Agreement and a $5,000,000 Master Credit, Security, and Account Purchase Agreement with IBS entities effective December 31, 2025, but received no funding under these facilities.
After Genefic elected to terminate the financing relationship, IBS declared Events of Default, accelerated a secured promissory note, and demanded various fees and charges, asserting a total of $1,162,246 (exclusive of interest and additional costs) plus additional qualifying collateral of not less than $875,000. IBS has also reserved extensive remedies, including potential control over deposit accounts, receivables, and pledged equity interests, and has issued default notices to Dalrada as corporate guarantor and to Brian Bonar as personal guarantor.
Dalrada disputes the asserted Events of Default, the demanded amounts, and the early termination fees, emphasizing that no funding was ever provided under the agreements. The company believes it has meritorious defenses and intends to vigorously contest IBS’s claims, while cautioning that if IBS were to prevail or exercise its reserved remedies, this could have a material adverse effect on Dalrada’s liquidity, financial condition, results of operations, and on Genefic’s operations, and could trigger defaults under other indebtedness.
Positive
- None.
Negative
- IBS is asserting obligations totaling $1,162,246 (plus additional interest, costs and potential collateral of at least $875,000), which Dalrada warns could have a material adverse effect on liquidity, financial condition and operations if IBS prevails or exercises reserved remedies and may trigger cross-defaults under other debt.
8-K Event Classification
3 items: 1.02, 2.04, 8.01
3 items
Item 1.02
Termination of a Material Definitive Agreement
Business
A significant contract was terminated, which may affect business operations or revenue.
Item 2.04
Triggering Events That Accelerate or Increase a Direct Financial Obligation
Financial
An event triggered acceleration or increase of an existing financial obligation, such as a debt covenant breach.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
MGA commitment: $20,000,000
MCSPA facility maximum amount: $5,000,000
Total amount asserted by IBS: $1,162,246
+5 more
8 metrics
MGA commitment
$20,000,000
Stated aggregate commitment under the Master Performance Standby Letter of Credit and Guaranty Agreement
MCSPA facility maximum amount
$5,000,000
Stated facility maximum amount under the Master Credit, Security, and Account Purchase Agreement
Total amount asserted by IBS
$1,162,246
Administrative reconciliation figure IBS states is presently due, exclusive of interest and additional costs
Accelerated note principal balance
$126,430
Stated principal balance of the Secured Promissory Note that IBS declared immediately due and payable
Warrant cash redemption amount
$225,000
Amount IBS demands upon exercising a purported right to redeem the warrant for cash
Rolling ledger losses
$399,214
“Rolling Ledger Losses” asserted by IBS for December 17, 2025 through August 28, 2026
Additional qualifying collateral demand
$875,000
Minimum value of additional qualifying collateral IBS demands to meet the Minimum Required Collateral Value
MGA and MCSPA early termination fees
$300,000
Early termination fees asserted by IBS under the MGA ($200,000) and MCSPA ($100,000)
Key Terms
Master Performance Standby Letter of Credit and Guaranty Agreement, Master Credit, Security, and Account Purchase Agreement, Events of Default, Minimum Required Collateral Value, +2 more
6 terms
Master Performance Standby Letter of Credit and Guaranty Agreement financial
"entered into (i) a Master Performance Standby Letter of Credit and Guaranty Agreement"
Master Credit, Security, and Account Purchase Agreement financial
"entered into (ii) a Master Credit, Security, and Account Purchase Agreement"
Events of Default financial
"IBS purports to declare that Events of Default have occurred and are continuing"
Events of default are specific breaches or failures listed in a loan, bond, or credit agreement that give lenders the right to act, such as demanding immediate repayment, raising interest rates, or taking secured assets. They matter to investors because triggering one is like setting off a financial alarm: it raises the chance of foreclosure, restructuring, or bankruptcy and can sharply reduce the value of a company’s stock or bonds and increase borrowing costs.
Minimum Required Collateral Value financial
"failure to maintain and substantiate a “Minimum Required Collateral Value” under Section 4"
Deposit Account Control Agreement financial
"subject to the Deposit Account Control Agreement; and (vi) the right to sell"
material adverse effect financial
"such actions could have a material adverse effect on the Company’s liquidity"
A material adverse effect is a significant negative change or event that substantially reduces a company’s business, financial condition, or future prospects — think of it like a sudden major engine failure that makes a car unreliable. Investors care because such an event can lower expected profits, trigger contract clauses (allowing counterparties to renegotiate or walk away), and prompt swift stock-price reassessment based on the higher risk and uncertainty.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What financing agreements did Dalrada Technology Group, Inc. (DHTI) and Genefic enter into with IBS?
Genefic entered into a $20,000,000 Master Performance Standby Letter of Credit and Guaranty Agreement and a $5,000,000 Master Credit, Security, and Account Purchase Agreement with IBS entities, effective December 31, 2025, along with related collateral and guaranty documents.
How much money did Dalrada (DHTI) and Genefic actually receive under the IBS financing agreements?
Dalrada states that no funding was provided under the financing agreements: no loans or advances were made, no accounts receivable were purchased, no standby letters of credit were drawn, and neither the company nor its subsidiaries received cash for the note or warrant.
What amount is IBS currently demanding from Dalrada (DHTI) and Genefic?
IBS asserts that $1,162,246 is presently due, excluding interest and additional costs. This figure aggregates items such as servicing invoices, legal and administration expenses, “rolling ledger losses,” a reinstated provisional credit override, accelerated note principal, warrant redemption, and early termination fees.
What additional collateral is IBS demanding from Genefic under the MGA?
IBS has demanded that Genefic deliver additional qualifying collateral with a value of not less than $875,000 to satisfy the Minimum Required Collateral Value, which IBS calculates as 25% of a $3,500,000 guarantee it asserts is outstanding under the MGA.
How does Dalrada (DHTI) respond to the Events of Default and payment demands asserted by IBS?
Dalrada disputes the asserted Events of Default and the amounts demanded, emphasizing that all demanded sums relate to unfunded facilities. The company believes it, Genefic and other credit parties have meritorious defenses and intends to vigorously contest any efforts by IBS to collect or exercise remedies.
What potential impact could the IBS dispute have on Dalrada’s (DHTI) financial condition?
Dalrada states that if IBS pursues and prevails on its claims or exercises reserved remedies—such as controlling deposit accounts, collecting receivables or foreclosing on pledged equity—these actions could have a material adverse effect on its liquidity, financial condition and results of operations and may cause defaults under other debt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
